Usefulness of the second heart sound for predicting pulmonary hypertension in patients with interstitial lung disease
Keywords:
Hypertension, pulmonary, Lung diseases, interstitial, Heart auscultation, Echocardiography, PhonocardiographyAbstract
CONTEXT AND OBJECTIVE: P2 hyperphonesis is considered to be a valuable finding in semiological diagnoses of pulmonary hypertension (PH). The aim here was to evaluate the accuracy of the pulmonary component of second heart sounds for predicting PH in patients with interstitial lung disease. DESIGN AND SETTING: Cross-sectional study at the University of Brasilia and Hospital de Base do Distrito Federal. METHODS: Heart sounds were acquired using an electronic stethoscope and were analyzed using phonocardiography. Clinical signs suggestive of PH, such as second heart sound (S2 ) in pulmonary area louder than in aortic area; P2> A2 in pulmonary area and P2 present in mitral area, were compared with Doppler echocardiographic parameters suggestive of PH. Sensitivity (S), specificity (Sp) and positive (LR+) and negative (LR-) likelihood ratios were evaluated. RESULTS: There was no significant correlation between S2 or P2 amplitude and PASP (pulmonary artery systolic pressure) (P = 0.185 and 0.115; P= 0.13 and 0.34, respectively). Higher S2 in pulmonary area than in aortic area, compared with all the criteria suggestive of PH, showed S = 60%, Sp= 22%; LR+ = 0.7; LR- = 1.7; while P2 > A2 showed S= 57%, Sp = 39%; LR+ = 0.9; LR- = 1.1; and P2 in mitral area showed: S= 68%, Sp = 41%; LR+ = 1.1; LR- = 0.7. All these signals together showed: S= 50%, Sp = 56%. CONCLUSIONS: The semiological signs indicative of PH presented low sensitivity and specificity levels for clinically diagnosing this comorbidity.
Downloads
References
Ryu JH, Daniels CE, Hartman TE, Yi ES. Diagnosis of interstitial lung diseases. Mayo Clin Proc. 2007;82(8):976-86.
Leslie KO. Pathology of interstitial lung disease. Clin Chest Med. 2004;25(4):657-703, vi.
Behr J, Ryu JH. Pulmonary hypertension in interstitial lung disease. Eur Respir J. 2008;31(6):1357-67.
Harris A. The second heart sound in health and in pulmonary hypertension. Am Heart J. 1970;79(2):145-8.
Fowler NO, Noble WJ, Giarratano SJ, Mannix EP. The clinical estimation of pulmonary hypertension accompanying mitral stenosis. Am Hear J. 1955;49(2):237-49.
Harris A, Sutton G. Second heart sound in normal subjects. Br Heart J. 1968;30(6):739-42.
Whitaker W. Clinical diagnosis of pulmonary hypertension in patients with mitral stenosis. Quarterly Journal of Medicine. 1954;23(89):105-12. Available from: http://qjmed.oxfordjournals.org/ content/23/1/105. Accessed in 2015 (Sep 15).
Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC); European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT),et al. Guidelines for diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2009;34(6):1219-63.
Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175-91.
Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440-63.
Berger M, Haimowitz A, Van Tosh A, Berdoff RL, Goldberg E. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol. 1985;6(2):359-65.
Fisher MR, Forfia PR, Chamera E, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med. 2009;179(7):615-21.
Ommen SR, Nishimura RA, Hurrell DG, Klarich KW. Assessment of right atrial pressure with 2-dimensional and Doppler echocardiography: a simultaneous catheterization and echocardiographic study. Mayo Clin Proc. 2000;75(1):24-9.
Currie PJ, Seward JB, Chan KL, et al. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler- catheterization study in 127 patients. J Am Coll Cardiol. 1985;6(4):750-6.
Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685-713; quiz 786-8.
Simonneau G, Galiè N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):5S-12S.
Olschewski H, Ghofrani HA, Walmrath D, et al. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis]. Pneumologie. 2000;54(3):133-42.
King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med. 2001;164(7):1171-81.
Lee P, Langevitz P, Alderdice CA, et al. Mortality in systemic sclerosis (scleroderma). Q J Med. 1992;82(298):139-48.
Handa T, Nagai S, Miki S, et al. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest. 2006;129(5):1246-52.
Chang B, Wigley FM, White B, Wise RA. Scleroderma patients with combined pulmonary hypertension and interstitial lung disease. J Rheumatol. 2003;30(11):2398-405.
Nadrous HF, Pellikka PA, Krowka MJ, et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest. 2005;128(4):2393-9.
Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest. 2006;129(3):746-52.
Potain C. Note sur les dédoublements normaux des bruits de coeur. Bull Mem Soc Méd Hop Paris. 1866;3:138.
Sabbah HN, Stein PD. Investigation of the theory and mechanism of the origin of the second heart sound. Circ Res. 1976;39(6):874-82.
Stein PD, Sabbah HN, Anbe DT, Khaja F. Hemodynamic and anatomic determinants of relative differences in amplitude of the aortic and pulmonary components of the second heart sound. Am J Cardiol. 1978;42(4):539-44.
Kusukawa R, Bruce DW, Sakamoto T, Mac Canon DM, Luisada AA. Hemodynamic determinants of the amplitude of the second heart sound. J Appl Physiol. 1966;21(3):938-46.
McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence- based clinical practice guidelines. Chest. 2004;126(1 Suppl):14S-34S.
Sutton G, Harris A, Leatham A. Second heart sound in pulmonary hypertension. Br Heart J. 1968;30(6):743-56.
D’Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary
pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991;115(5):343-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 São Paulo Medical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
